Clinical Trial Update: Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing BAT2506 with Simponi in participants with active psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• BAT2506
• Simponi (golimumab)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED